After transduction, CD1d expression and lysosomal

storage

After transduction, CD1d expression and lysosomal

storage (using the fluorescent dye LysoTracker® green DND-26 (Invitrogen), 200 nM in D-PBS for 10 min at room temperature) was assessed by FACS staining and EBV-B-cell lines were sorted for CD1d positive cells using a MoFlo sorter. NPC1 genotypes of the donors used for the generation of the lines are NPC1 1920delG, IVS9-1009G>A and data unavailable and for NPC1 heterozygote 1920delG and data unavailable. KU-60019 concentration NPC1 patient-derived iNKT-cell lines were used at least 14 days after re-stimulation. Antigen presenting cells (human CD1d cherry lentiviral transfected THP1 cells) were left untreated, pulsed with αGalCer (100 ng/mL), Gal(α1-2)GalCer (150 ng/mL) or C20:2 (15 ng/mL) or matured with the Toll like receptor 7/8 agonist R848 (5 μg/mL Invivogen).

THP1 cells were co-cultured with iNKT cells at a 2:1 THP1 to iNKT-cell ratio in 96 U bottom wells and supernatant was harvested after 36 h. IFN-γ (MabTech), IL-4 (BD Pharmingen) and GM-CSF (eBioscience) levels in the supernatant were measured by ELISA according to manufacturers protocols. selleck screening library NPC1 patient or NPC1 heterozygote human or mouse CD1d lentiviral transduced EBV transformed B-cell lines were left untreated or pulsed with αGalCer (50 ng/mL), Gal(α1-2)GalCer (150 ng/mL) or C20:2 (15 ng/mL) before being used as antigen presenting cells in iNKT-cell stimulation assays as described above using iNKT cells prepared from a healthy donor. As we were unable to transduce control blood due to the donors working within the department the control B-cell line C1R was transfected with human CD1d cyan fluorescent protein and used. Statistical significance was tested by a one-way ANOVA with a Tukey post-test using Prism v4 (GraphPad Software

Inc, La Jolla, CA, USA) with *p < 0.05 and **p < 0.01 considered statistically significant. A.O.S. was funded by the MRC (G0700851), N.P. is funded Fossariinae by the MRC (G0800158), D.t.V. by Action Medical Research (SP4023) and Niemann-Pick Disease Group UK and D.A.S. by SOAR-NPC. M.S. is supported by Cancer Research UK (grant C399/A2291 to V.C.). This work was supported in part by the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and a Bench to Bedside grant from the Office of Rare Diseases (F.D.P.). N.M.Y. was supported by APMRF and DART. The authors declare no financial or commercial conflict of interest. Disclaimer: Supplementary materials have been peer-reviewed but not copyedited. Figure S1. Gating Doublets were excluded by FSC-H versus FSC-A and lymphocytes identified by size and granularity (FSC-A versus SSC-A). Viable lymphocytes were selected on the basis of exclusion of live/dead aqua stain. Total T cells were identified as CD3+ viable lymphocytes and iNKT cells as either 6B11+CD3+ or tetramer+CD3+ cells.

Comments are closed.